Pulse and continuous oral norfloxacin treatment of experimentally induced Escherichia coli infection in broiler chicks and Turkey poults

Acta Veterinaria Hungarica

Volumn 50, Issue 2, 2002, Pages 199-210

  Sarkozy G ^a   Semjen G ^a   Laczay, P ^a   Horvath E ^b   Schmidt, J ^c  

^a SZENT ISTVÁN UNIVERSITY   (Hungary)

^b State Control Institute for Veterinary Biologicals   (Hungary)

^c Ceva Phylaxia Veterinary Biologicals Co Ltd   (Hungary)

Author keywords

Continuous dosing; E. coli; Norfloxacin; Oral treatment; Pulse dosing

Indexed keywords

DRINKING WATER; NORFLOXACIN; VETRIFLOX 200;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIUM ISOLATION; CHICKEN; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; ENTEROBACTER INFECTION; ESCHERICHIA COLI; MORTALITY; NONHUMAN; POULTRY; TURKEY (BIRD); VACCINATION; WEIGHT GAIN;

ANIMALIA; AVES; AVIAN INFECTIOUS BRONCHITIS VIRUS; BACTERIA (MICROORGANISMS); ENTEROBACTER; ESCHERICHIA COLI; GALLUS GALLUS; MELEAGRIS GALLOPAVO;

EID: 0036375192     PISSN: 02366290     EISSN: None     Source Type: Journal    
DOI: 10.1556/AVet.50.2002.2.9     Document Type: Article

References (24)

1. Characterization of E. coli isolated from cases of avian colibacillosis
2. Therapeutic effects of water medication of Neomycin on experimentally transmitted colibacillosis in chicks
3. Colibacillosis
4. Comparison of the efficacies of three fluoroquinolone antimicrobial agents, given as continuous or pulsed water medication, against E. coli infection in chickens
5. E. coli challenge in chickens selected for high or low antibody response and differing in haplotypes at the major histocompatibility complex
6. Hemagglutination, hydrophobicity, enterotoxigenicity and drug resistance characteristics of avian E. coli
7. Discovery and development of new antimicrobial agents
8. Comparative studies on the pharmacokinetics of norfloxacin in chickens, turkeys and geese after a single oral administration
9. Efficacy of norfloxacin nicotinate treatment of broiler breeders against Haemophilus paragallinarum
10. Twenty-four-hour area under the concentration-time curve/MIC ratio as a generic predictor of fluoroquinolone antimicrobial effect using three strains of Pseudomonas aeruginosa and in vitro pharmacodynamic model
11. Pharmacokinetics of enrofloxacin in clinically normal dogs and mice and drug pharmacodynamics in neutropenic mice with E. coli and staphylococcal infections
12. The post-antimicrobial suppressive effect of quinolone agents
13. In vitro antibiogram studies of E. coli in chickens
14. Comparison of plasmid profile analysis, antibiogram testing, resistotyping and biotyping in the identification of E. coli isolates from poultry
15. In vitro susceptibility of avian E. coli and Pasteurella multocida to danofloxacin and five other antimicrobials
16. DNA gyrase: Structure and function
17. Comparative study on the efficacy of difloxacin and enrofloxacin in an experimentally induced Escherichia coli infection in broilers
18. Pharmacodynamics of the fluoroquinolones
19. The clinical, pathological and microbiological outcome of an Escherichia coli O2:K1 infection in avian pneumovirus infected turkeys
20. Serotypes of E. coli pathological conditions in poultry and their antibiogram
21. Norfloxacin - A review of pharmacology and tissue penetration
22. Norfloxacin: A new targeted fluoroquinolone antimicrobial agent
23. Enterobacteriaceae